In-situ Hybridization (ISH) Market Size In 2022 : Rising Demand In Molecular Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies Driving the growth of Industry | 95 Pages Report

In-situ Hybridization (ISH) Market Growth Insights In 2022 : In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough (e.g., plant seeds, Drosophila embryos), in the entire tissue (whole mount ISH), in cells, and in circulating tumor cells (CTCs).

In situ hybridization is used to reveal the location of specific nucleic acid sequences on chromosomes or in tissues, a crucial step for understanding the organization, regulation, and function of genes. The key techniques currently in use include: in situ hybridization to mRNA with oligonucleotide and RNA probes (both radio-labelled and hapten-labelled); analysis with light and electron microscopes; whole mount in situ hybridization; double detection of RNAs and RNA plus protein; and fluorescent in situ hybridization to detect chromosomal sequences. DNA ISH can be used to determine the structure of chromosomes. Fluorescent DNA ISH (FISH) can, for example, be used in medical diagnostics to assess chromosomal integrity. RNA ISH (RNA in situ hybridization) is used to measure and localize RNAs (mRNAs, lncRNAs, and miRNAs) within tissue sections, cells, whole mounts, and circulating tumor cells (CTCs).

Market Analysis and Insights: Global In-situ Hybridization (ISH) Market

The global In-situ Hybridization (ISH) market size is projected to reach USD million by 2026, from USD million in 2020, at a CAGR of % during 2021-2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global In-situ Hybridization (ISH) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global In-situ Hybridization (ISH) market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global In-situ Hybridization (ISH) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global In-situ Hybridization (ISH) market.

Global In-situ Hybridization (ISH) Scope and Segment

In-situ Hybridization (ISH) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global In-situ Hybridization (ISH) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.


Leading Key Players In the global In-situ Hybridization (ISH) market 2022:

  • ABBott Laboratories
  • F.Hoffmann-La Roche
  • Thermofisher Scientific
  • Merck
  • Agilent Technologies
  • Perkin Elmer
  • Danaher Corporation
  • Exiqon
  • Biogenex Laboratories
  • Advanced Cell Diagnostics
  • Bio SB

    Based on product, the In-situ Hybridization (ISH) market is segmented into Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ Hybridization and other. The In-situ Hybridization (ISH) products segment dominated the In-situ Hybridization (ISH) market in 2022. Rising incidences and new product launches expected to drive the segment growth.

    Get a Sample PDF of report –

    For More Related Reports Click Here :

  • About the author

    Winifred Gerald

    Add Comment

    Click here to post a comment

    Recent Posts